Centiva Capital, LP Eli Lilly & CO Transaction History

Centiva Capital, LP

$4.79 Billion
Q3 2024

A detailed history of Centiva Capital, LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Centiva Capital, LP holds 26,826 shares of LLY stock, worth $21.3 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares

26,826

Previous 1,300 1963.54%

Holding current value

$21.3 Million

Previous $1.18 Million 1920.92%

% of portfolio

0.5%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $20.6 Million - $25.6 Million	26,649 Added 15055.93%	26,826 $23.8 Million
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $1.22 Million - $1.53 Million	-1,680 Reduced 90.47%	177 $160,000
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $779,335 - $1.04 Million	-1,316 Reduced 41.47%	1,857 $1.44 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $1.13 Million - $1.33 Million	2,149 Added 209.86%	3,173 $1.85 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $1.06 Million - $1.46 Million	-2,439 Reduced 70.43%	1,024 $550,000
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $1.21 Million - $1.62 Million	3,463 New	3,463 $1.62 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $5.29 Million - $6.21 Million	18,983 Added 1866.57%	20,000 $6.48 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $365,196 - $449,426	-1,648 Reduced 61.84%	1,017 $235,000
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $83,053 - $107,428	-460 Reduced 14.72%	2,665 $612,000
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $470,776 - $609,442	-2,865 Reduced 47.83%	3,125 $584,000
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $2.45 Million - $3.24 Million	-18,773 Reduced 75.81%	5,990 $1.01 Million
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $2.54 Million - $2.94 Million	17,405 Added 236.55%	24,763 $3.67 Million
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $1.15 Million - $1.38 Million	-8,418 Reduced 53.36%	7,358 $1.21 Million
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $147,979 - $183,156	-1,243 Reduced 7.3%	15,776 $2.19 Million
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $1.41 Million - $1.75 Million	13,208 Added 346.58%	17,019 $2.24 Million
Q3 2019 Nov 13, 2019	BUY	$106.79 - $116.16 $406,869 - $442,569	3,810 Added 381000.0%	3,811 $426,000
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $2.91 Million - $3.42 Million	-26,116 Reduced 100.0%	1 $0
Q4 2018 Feb 13, 2019	BUY	$105.9 - $118.64 $2.77 Million - $3.1 Million	26,117 New	26,117 $3.02 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.

Account

Centiva Capital, LP Eli Lilly & CO Transaction History